These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30503143)

  • 1. Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.
    Lang C; Campbell KR; Ryan BJ; Carling P; Attar M; Vowles J; Perestenko OV; Bowden R; Baig F; Kasten M; Hu MT; Cowley SA; Webber C; Wade-Martins R
    Cell Stem Cell; 2019 Jan; 24(1):93-106.e6. PubMed ID: 30503143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses.
    Fernandes HJR; Patikas N; Foskolou S; Field SF; Park JE; Byrne ML; Bassett AR; Metzakopian E
    Cell Rep; 2020 Oct; 33(2):108263. PubMed ID: 33053338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.
    Fernandes HJ; Hartfield EM; Christian HC; Emmanoulidou E; Zheng Y; Booth H; Bogetofte H; Lang C; Ryan BJ; Sardi SP; Badger J; Vowles J; Evetts S; Tofaris GK; Vekrellis K; Talbot K; Hu MT; James W; Cowley SA; Wade-Martins R
    Stem Cell Reports; 2016 Mar; 6(3):342-56. PubMed ID: 26905200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
    Sandor C; Robertson P; Lang C; Heger A; Booth H; Vowles J; Witty L; Bowden R; Hu M; Cowley SA; Wade-Martins R; Webber C
    Hum Mol Genet; 2017 Feb; 26(3):552-566. PubMed ID: 28096185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.
    Woodard CM; Campos BA; Kuo SH; Nirenberg MJ; Nestor MW; Zimmer M; Mosharov EV; Sulzer D; Zhou H; Paull D; Clark L; Schadt EE; Sardi SP; Rubin L; Eggan K; Brock M; Lipnick S; Rao M; Chang S; Li A; Noggle SA
    Cell Rep; 2014 Nov; 9(4):1173-82. PubMed ID: 25456120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.
    Heger LM; Wise RM; Hees JT; Harbauer AB; Burbulla LF
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.
    Bogetofte H; Ryan BJ; Jensen P; Schmidt SI; Vergoossen DLE; Barnkob MB; Kiani LN; Chughtai U; Heon-Roberts R; Caiazza MC; McGuinness W; Márquez-Gómez R; Vowles J; Bunn FS; Brandes J; Kilfeather P; Connor JP; Fernandes HJR; Caffrey TM; Meyer M; Cowley SA; Larsen MR; Wade-Martins R
    Cell Rep; 2023 Mar; 42(3):112180. PubMed ID: 36870058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding Parkinson's disease - iPSC-derived models in the OMICs era.
    Krach F; Bogiongko ME; Winner B
    Mol Cell Neurosci; 2020 Jul; 106():103501. PubMed ID: 32439399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S
    Grigor'eva EV; Kopytova AE; Yarkova ES; Pavlova SV; Sorogina DA; Malakhova AA; Malankhanova TB; Baydakova GV; Zakharova EY; Medvedev SP; Pchelina SN; Zakian SM
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901867
    [No Abstract]   [Full Text] [Related]  

  • 11. Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis.
    Onal G; Yalçın-Çakmaklı G; Özçelik CE; Boussaad I; Şeker UÖŞ; Fernandes HJR; Demir H; Krüger R; Elibol B; Dökmeci S; Salman MM
    J Neurochem; 2024 Sep; 168(9):2543-2560. PubMed ID: 38641924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
    Beevers JE; Caffrey TM; Wade-Martins R
    Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
    Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
    Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
    Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
    Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell Transcriptomics and In Vitro Lineage Tracing Reveals Differential Susceptibility of Human iPSC-Derived Midbrain Dopaminergic Neurons in a Cellular Model of Parkinson's Disease.
    Cardo LF; Monzón-Sandoval J; Li Z; Webber C; Li M
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease.
    Schöndorf DC; Ivanyuk D; Baden P; Sanchez-Martinez A; De Cicco S; Yu C; Giunta I; Schwarz LK; Di Napoli G; Panagiotakopoulou V; Nestel S; Keatinge M; Pruszak J; Bandmann O; Heimrich B; Gasser T; Whitworth AJ; Deleidi M
    Cell Rep; 2018 Jun; 23(10):2976-2988. PubMed ID: 29874584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
    Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
    PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Parkinson's disease using induced pluripotent stem cells.
    Byers B; Lee HL; Reijo Pera R
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
    Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
    Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.